These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33017613)

  • 1. Filling the gaps on stroke research: Focus on inflammation and immunity.
    Levard D; Buendia I; Lanquetin A; Glavan M; Vivien D; Rubio M
    Brain Behav Immun; 2021 Jan; 91():649-667. PubMed ID: 33017613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Responses and Anti-inflammatory Strategies in a Clinically Relevant Model of Thromboembolic Ischemic Stroke with Reperfusion.
    Drieu A; Buendia I; Levard D; Hélie P; Brodin C; Vivien D; Rubio M
    Transl Stroke Res; 2020 Jun; 11(3):481-495. PubMed ID: 31522409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.
    Candelario-Jalil E; Paul S
    Exp Neurol; 2021 Jan; 335():113494. PubMed ID: 33035516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia.
    Macrae IM
    Br J Pharmacol; 2011 Oct; 164(4):1062-78. PubMed ID: 21457227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion.
    Shi L; Rocha M; Leak RK; Zhao J; Bhatia TN; Mu H; Wei Z; Yu F; Weiner SL; Ma F; Jovin TG; Chen J
    J Cereb Blood Flow Metab; 2018 Dec; 38(12):2073-2091. PubMed ID: 30191760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke and Translational Research - Review of Experimental Models with a Focus on Awake Ischaemic Induction and Anaesthesia.
    Mosneag IE; Flaherty SM; Wykes RC; Allan SM
    Neuroscience; 2024 Jul; 550():89-101. PubMed ID: 38065289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of sex and age on T cell immunity and ischemic stroke outcomes.
    Ahnstedt H; McCullough LD
    Cell Immunol; 2019 Nov; 345():103960. PubMed ID: 31519365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease.
    Stanzione R; Forte M; Cotugno M; Bianchi F; Marchitti S; Rubattu S
    Cell Mol Neurobiol; 2022 Apr; 42(3):545-556. PubMed ID: 32996044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
    Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
    Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.
    Maysami S; Wong R; Pradillo JM; Denes A; Dhungana H; Malm T; Koistinaho J; Orset C; Rahman M; Rubio M; Schwaninger M; Vivien D; Bath PM; Rothwell NJ; Allan SM
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):596-605. PubMed ID: 26661169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors in the treatment of cerebral ischemia.
    Flores JJ; Zhang Y; Klebe DW; Lekic T; Fu W; Zhang JH
    Expert Opin Pharmacother; 2014 Apr; 15(5):659-80. PubMed ID: 24491068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune system in stroke: clinical challenges and their translation to experimental research.
    Smith CJ; Lawrence CB; Rodriguez-Grande B; Kovacs KJ; Pradillo JM; Denes A
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):867-87. PubMed ID: 23673977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do stroke models model stroke?
    Mergenthaler P; Meisel A
    Dis Model Mech; 2012 Nov; 5(6):718-25. PubMed ID: 23115201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Wahlgren NG; Ahmed N
    Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
    Schmidt A; Minnerup J; Kleinschnitz C
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?
    Rayasam A; Hsu M; Kijak JA; Kissel L; Hernandez G; Sandor M; Fabry Z
    Immunology; 2018 Jul; 154(3):363-376. PubMed ID: 29494762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-Induced Neuroprotection in Focal Cerebral Ischemia in the ALIAS Trial: Does Severity, Mechanism, and Time of Infusion Matter?
    Khatri R; Afzal MR; Rodriguez GJ; Maud A; Miran MS; Qureshi MA; Cruz-Flores S; Qureshi AI
    Neurocrit Care; 2018 Feb; 28(1):60-64. PubMed ID: 28439774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells.
    Jin R; Yang G; Li G
    J Leukoc Biol; 2010 May; 87(5):779-89. PubMed ID: 20130219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.